Search Results - "Cha, Hyuk‑Jin"

Refine Results
  1. 1

    Stochastic and Heterogeneous Cancer Cell Migration: Experiment and Theory by Kwon, Taejin, Kwon, Ok-Seon, Cha, Hyuk-Jin, Sung, Bong June

    Published in Scientific reports (08-11-2019)
    “…Cell migration, an essential process for normal cell development and cancer metastasis, differs from a simple random walk: the mean-square displacement (〈(Δ r…”
    Get full text
    Journal Article
  2. 2

    Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis by Cha, Young, Han, Min-Joon, Cha, Hyuk-Jin, Zoldan, Janet, Burkart, Alison, Jung, Jin Hyuk, Jang, Yongwoo, Kim, Chun-Hyung, Jeong, Ho-Chang, Kim, Byung-Gyu, Langer, Robert, Kahn, C. Ronald, Guarente, Leonard, Kim, Kwang-Soo

    Published in Nature cell biology (01-05-2017)
    “…A hallmark of cancer cells is the metabolic switch from oxidative phosphorylation (OXPHOS) to glycolysis, a phenomenon referred to as the ‘Warburg effect’,…”
    Get full text
    Journal Article
  3. 3

    In silico drug repositioning: from large-scale transcriptome data to therapeutics by Kwon, Ok-Seon, Kim, Wankyu, Cha, Hyuk-Jin, Lee, Haeseung

    Published in Archives of pharmacal research (01-10-2019)
    “…Drug repositioning is an attractive alternative to conventional drug development when new beneficial effects of old drugs are clinically validated because…”
    Get full text
    Journal Article
  4. 4

    Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer by Kwon, Ok-Seon, Lee, Haeseung, Kong, Hyeon-Joon, Kwon, Eun-Ji, Park, Ji Eun, Lee, Wooin, Kang, Seungmin, Kim, Mirang, Kim, Wankyu, Cha, Hyuk-Jin

    Published in Oncogene (04-06-2020)
    “…Despite the continual discovery of promising new cancer targets, drug discovery is often hampered by the poor druggability of these targets. As such,…”
    Get full text
    Journal Article
  5. 5

    Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif by Kim, Yun-Jeong, Lim, Bumhee, Kim, Seo Young, Shin, Yoon-Ze, Yu, Nayoung, Shin, Eun-Kyung, Lee, Jae-Eon, Jeon, Yong Hyun, Kim, Dae-Duk, Lee, Jeeyeon, Cha, Hyuk-Jin

    Published in Biomedicine & pharmacotherapy (01-07-2024)
    “…Sorafenib (BAY 43–9006) was developed as a multi-kinase inhibitor to treat advanced renal cell, hepatocellular, and thyroid cancers. The cytotoxic effect of…”
    Get full text
    Journal Article
  6. 6

    Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways by Park, Ju-Chan, Kim, Yun-Jeong, Hwang, Gue-Ho, Kang, Chan Young, Bae, Sangsu, Cha, Hyuk-Jin

    Published in Nature communications (11-05-2024)
    “…Precise genome editing is crucial for establishing isogenic human disease models and ex vivo stem cell therapy from the patient-derived hPSCs. Unlike…”
    Get full text
    Journal Article
  7. 7

    Inhibition of pluripotent stem cell-derived teratoma formation by small molecules by Lee, Mi-Ok, Moon, Sung Hwan, Jeong, Ho-Chang, Yi, Ji-Yeon, Lee, Tae-Hee, Shim, Sung Han, Rhee, Yong-Hee, Lee, Sang-Hun, Oh, Seok-Jeong, Lee, Moo-Yeol, Han, Min-Joon, Cho, Yee Sook, Chung, Hyung-Min, Kim, Kwang-Soo, Cha, Hyuk-Jin

    “…The future of safe cell-based therapy rests on overcoming teratoma/tumor formation, in particular when using human pluripotent stem cells (hPSCs), such as…”
    Get full text
    Journal Article
  8. 8

    Optimizing tissue-clearing conditions based on analysis of the critical factors affecting tissue-clearing procedures by Kim, June Hoan, Jang, Min Jee, Choi, Jungyoon, Lee, Eunsoo, Song, Kyung–Deok, Cho, Jaeho, Kim, Keun-Tae, Cha, Hyuk-Jin, Sun, Woong

    Published in Scientific reports (24-08-2018)
    “…Tissue-clearing techniques have received great attention for volume imaging and for the potential to be applied in optical diagnosis. In principle, tissue…”
    Get full text
    Journal Article
  9. 9

    A Theoretical Model for the Cell Cycle and Drug Induced Cell Cycle Arrest of FUCCI Systems with Cell-to-Cell Variation during Mitosis by Bae, Hyeonjeong, Go, Young-Hyun, Kwon, Taejin, Sung, Bong June, Cha, Hyuk-Jin

    Published in Pharmaceutical research (01-04-2019)
    “…Purpose Since the molecular mechanism of the cell cycle was established, various theoretical models of this process have been developed. A recent study…”
    Get full text
    Journal Article
  10. 10

    Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells by Kong, Hyeon‑Joon, Kwon, Eun‑Ji, Kwon, Ok‑Seon, Lee, Haeseung, Choi, Jeong‑Yun, Kim, Yung‑Jeong, Kim, Wankyu, Cha, HyukJin

    Published in International journal of oncology (01-01-2021)
    “…Serpin family E member 1 (SERPINE1), a serine proteinase inhibitor, serves as an important regulator of extra-cellular matrix remodeling. Emerging evidence…”
    Get full text
    Journal Article
  11. 11

    TGFβ promotes YAP‐dependent AXL induction in mesenchymal‐type lung cancer cells by Choi, Jeong‐Yun, Lee, Haeseung, Kwon, Eun‐Ji, Kong, Hyeon‐Joon, Kwon, Ok‐Seon, Cha, HyukJin

    Published in Molecular oncology (01-02-2021)
    “…Through integration of multiple large database, two oncogenic signatures (YAP conserved and TGFβ‐up signatures) were commonly upregulated in the cancer cell…”
    Get full text
    Journal Article
  12. 12

    Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer by Bae, Gab-Yong, Choi, So-Jung, Lee, Ji-Seon, Jo, Jisuk, Lee, Jinseon, Kim, Jhingook, Cha, Hyuk-Jin

    Published in Oncotarget (01-12-2013)
    “…Loss of E-cadherin, a hallmark of epithelial-mesenchymal transition (EMT), can significantly affect metastatic dissemination. However, the molecular mechanism…”
    Get full text
    Journal Article
  13. 13

    Technical approaches to induce selective cell death of pluripotent stem cells by Jeong, Ho-Chang, Cho, Seung-Ju, Lee, Mi-Ok, Cha, Hyuk-Jin

    “…Despite the recent promising results of clinical trials using human pluripotent stem cell (hPSC)-based cell therapies for age-related macular degeneration…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer by Hong, Soon-Ki, Lee, Haeseung, Kwon, Ok-Seon, Song, Na-Young, Lee, Hyo-Ju, Kang, Seungmin, Kim, Jeong-Hwan, Kim, Mirang, Kim, Wankyu, Cha, Hyuk-Jin

    Published in Molecular cancer (18-12-2018)
    “…Even when targets responsible for chemoresistance are identified, drug development is often hampered due to the poor druggability of these proteins. We…”
    Get full text
    Journal Article
  16. 16

    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer by Kwon, Ok-Seon, Hong, Soon-Ki, Kwon, Soo-Jung, Go, Young-Hyun, Oh, Ensel, Cha, Hyuk-Jin

    Published in Cancer letters (10-09-2017)
    “…Abstract Mesenchymal-type cancers after epithelial mesenchymal transition (EMT) were recently shown to acquire chemoresistance through expressing EMT specific…”
    Get full text
    Journal Article
  17. 17

    Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors by Kwon, Eun-Ji, Cha, Hyuk-Jin, Lee, Haeseung

    Published in iScience (19-04-2024)
    “…Epidermal growth factor receptor inhibitors (EGFRi) have exhibited promising clinical outcomes in the treatment of various cancers. However, their widespread…”
    Get full text
    Journal Article
  18. 18

    Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells by Park, Ju-Chan, Park, Mihn Jeong, Lee, Seung-Yeon, Kim, Dayeon, Kim, Keun-Tae, Jang, Hyeon-Ki, Cha, Hyuk-Jin

    Published in Stem cell research & therapy (20-06-2023)
    “…Owing to the advances in genome editing technologies, research on human pluripotent stem cells (hPSCs) have recently undergone breakthroughs that enable…”
    Get full text
    Journal Article
  19. 19

    TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells by Kim, Yun-Jeong, Go, Young-Hyun, Jeong, Ho-Chang, Kwon, Eun-Ji, Kim, Seong-Min, Cheong, Hyun Sub, Kim, Wantae, Shin, Hyoung Doo, Lee, Haeseung, Cha, Hyuk-Jin

    Published in Experimental & molecular medicine (01-01-2023)
    “…Genetic alterations have been reported for decades in most human embryonic stem cells (hESCs). Survival advantage, a typical trait acquired during long-term in…”
    Get full text
    Journal Article
  20. 20

    Senescent Growth Arrest in Mesenchymal Stem Cells Is Bypassed by Wip1‐Mediated Downregulation of Intrinsic Stress Signaling Pathways by Lee, Ji‐Seon, Lee, Mi‐Ok, Moon, Bo‐Hyun, Shim, Sung Han, Fornace, Albert J., Cha, HyukJin

    Published in Stem cells (Dayton, Ohio) (01-08-2009)
    “…Human mesenchymal stem cells (hMSCs) have been widely studied as a source of primary adult stem cells for cell therapy because of their multidifferentiation…”
    Get full text
    Journal Article